Emtriva

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2003
01220032003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
  • Drugs in R&D
  • 2004
Gilead Sciences is developing a fixed-dose co-formulation of two of its reverse transcriptase inhibitors, emtricitabine [Emtriva… (More)
Is this relevant?
2004
2004
Emtricitabine (FTC; Emtriva), a potent deoxycytidine nucleoside reverse transcriptase inhibitor, has recently been approved by… (More)
Is this relevant?
Review
2004
Review
2004
In recent years, significant progress has been made towards the chemotherapy (and prophylaxis) of HIV infections. This progress… (More)
Is this relevant?
2004
2004
 
Is this relevant?
2003
2003
  • AIDS patient care and STDs
  • 2003
 
Is this relevant?
2003
2003
  • Project Inform perspective
  • 2003
The FDA approved FTC (emtricitabine, Emtriva) in July 2003 for use by adults in combination with other anti-HIV drugs. FTC is a… (More)
Is this relevant?